Publikationsdatum:
2013-11-01
Beschreibung:
Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-alpha pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists. One of these compounds, AdipoR agonist (AdipoRon), bound to both AdipoR1 and AdipoR2 in vitro. AdipoRon showed very similar effects to adiponectin in muscle and liver, such as activation of AMPK and PPAR-alpha pathways, and ameliorated insulin resistance and glucose intolerance in mice fed a high-fat diet, which was completely obliterated in AdipoR1 and AdipoR2 double-knockout mice. Moreover, AdipoRon ameliorated diabetes of genetically obese rodent model db/db mice, and prolonged the shortened lifespan of db/db mice on a high-fat diet. Thus, orally active AdipoR agonists such as AdipoRon are a promising therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Okada-Iwabu, Miki -- Yamauchi, Toshimasa -- Iwabu, Masato -- Honma, Teruki -- Hamagami, Ken-ichi -- Matsuda, Koichi -- Yamaguchi, Mamiko -- Tanabe, Hiroaki -- Kimura-Someya, Tomomi -- Shirouzu, Mikako -- Ogata, Hitomi -- Tokuyama, Kumpei -- Ueki, Kohjiro -- Nagano, Tetsuo -- Tanaka, Akiko -- Yokoyama, Shigeyuki -- Kadowaki, Takashi -- England -- Nature. 2013 Nov 28;503(7477):493-9. doi: 10.1038/nature12656. Epub 2013 Oct 30.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉1] Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan [2] Department of Integrated Molecular Science on Metabolic Diseases, 22nd Century Medical and Research Center, The University of Tokyo, Tokyo 113-0033, Japan [3] Department of Molecular Medicinal Sciences on Metabolic Regulation, 22nd Century Medical and Research Center, The University of Tokyo, Tokyo 113-0033, Japan [4].〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24172895" target="_blank"〉PubMed〈/a〉
Schlagwort(e):
Adenylate Kinase/metabolism
;
Adiponectin/metabolism/pharmacology
;
Adipose Tissue, White/drug effects/metabolism/pathology
;
Administration, Oral
;
Animals
;
Diabetes Mellitus, Type 2/complications/*drug therapy/metabolism/prevention &
;
control
;
Diet, High-Fat
;
Drug Evaluation, Preclinical
;
Dyslipidemias/drug therapy
;
Enzyme Activation/drug effects
;
Glucose Intolerance/drug therapy
;
Inflammation/drug therapy
;
Insulin Resistance
;
Liver/drug effects/metabolism/pathology
;
Longevity/*drug effects
;
Mice
;
Mitochondria/drug effects/metabolism
;
Muscle Fibers, Skeletal/cytology/drug effects
;
Muscles/cytology
;
Obesity/complications/drug therapy/genetics/*physiopathology
;
Oxidative Stress/drug effects
;
PPAR alpha/metabolism
;
Piperidines/administration & dosage/metabolism/*pharmacology/therapeutic use
;
Receptors, Adiponectin/*agonists/deficiency/genetics/metabolism
;
Signal Transduction/drug effects
;
Small Molecule Libraries/chemistry
;
Transcription Factors/biosynthesis
;
Triglycerides/metabolism
Print ISSN:
0028-0836
Digitale ISSN:
1476-4687
Thema:
Biologie
,
Chemie und Pharmazie
,
Medizin
,
Allgemeine Naturwissenschaft
,
Physik
Permalink
